Document is current

Any future updates will be listed below

Correction: Ibrutinib, a Bruton’s tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma

Crossref DOI link: https://doi.org/10.1186/s13046-025-03304-y

Published Online: 2025-02-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark